News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Two top-cited 2023 papers on Annals Of Oncology – ESMO
David Miles and Juan Pascual
Dec 5, 2024, 15:37

Two top-cited 2023 papers on Annals Of Oncology – ESMO

ESMO shared on LinkedIn:

“As Annals Of Oncology 35th Anniversary is commemorated, here are two top-cited 2023 papers:

‘Primary results from IMpassion131: Paclitaxel with or without atezolizumab for triple-negative breast cancer’

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

Authors: D. Miles, J. Gligorov, F. André, D. Cameron, A. Schneeweiss, C. Barrios, B. Xu, A. Wardley, D. Kaen, L. Andrade,  V. Semiglazov, M. Reinisch, S. Patel, M. Patre, L. Morales, S.L. Patel, M. Kaul, T. Barata, J. O’Shaughnessy

Annals Of Oncology

‘ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer’

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

Authors: J. Pascual, G. Attard, F.-C. Bidard, G. Curigliano, L. De Mattos-Arruda, M. Diehn, A. Italiano, J. Lindberg, J.D. Merker, C. Montagut, N. Normanno, K. Pantel, G. Pentheroudakis, S. Popat, J.S. Reis-Filho, J. Tie, J. Seoane, N. Tarazona, T. Yoshino, N.C. Turner

Annals Of Oncology

A. Italiano A. Schneeweiss A. Wardley Annals of Oncology B. Xu C. Barrios C. Montagut cancer D. Cameron D. Kaen D. Miles ESMO F. André F.-C. Bidard G Curigliano G Pentheroudakis G. Attard J. Gligorov J. Lindberg J. O’Shaughnessy J. Pascual J. Seoane J. Tie J.D. Merker J.S. Reis-Filho K. Pantel L. Andrade L. De Mattos-Arruda L. Morales M. Diehn M. Kaul M. Patre M. Reinisch N. Normanno N. Tarazona N.C. Turner OncoDaily Oncology S. Patel S. Popat S.L. Patel T. Barata T. Yoshino V. Semiglazov
Special Coverage
Insight
Jan 5, 2025, 18:37
Roupen Odabashian: How to Study with AI
Insight
Jan 5, 2025, 18:34
Nazik Hammad: Faculty Development among African Oncologists
Blog
Jan 5, 2025, 18:32
David Agus: Shocking that there is a lack of trust in science
Insight
Jan 5, 2025, 18:26
Rahul Gosain: GISeries with Shubham Pant
Insight
Jan 5, 2025, 18:24
Monika Pansari: Introducing Aarambh
Insight
Jan 5, 2025, 18:21
Elisa Agostinetto: Drug-drug interactions between palbociclib and PPI in breast cancer
Blog
Jan 5, 2025, 18:13
Min-Han Tan: Cancer patients deserve the most informed treatment options
Blog
Jan 5, 2025, 18:11
Rolling into 2025 with hope, purpose and determination - City of Hope
Blog
Jan 5, 2025, 17:52
Zoë Mullan: Happy New Year from the Lancet Global Health team
Blog
Jan 5, 2025, 17:49
Amit Kumar Jain: The intricate and compelling journey of cancer
Blog
Jan 5, 2025, 17:46
A powerful moment during the annual POHER medical research and mentorship symposium
Career
Jan 5, 2025, 17:42
Alexandra Bailey's journey to Dana-Farber Cancer Institute